Tomohiro Arakawa

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Analysis of hepatitis B surface antigen (HBsAg) using high‐sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays

Itaru Ozeki, Tomoaki Nakajima, Hirokazu Suii et al. · Hepatology Research · 2017 · 30 citations · Full text

Medicine, Infectious Diseases, Hepatology +6

Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients

Itaru Ozeki, Jun Akaike, Yoshiyasu Karino et al. · Journal of Gastroenterology · 2011 · 27 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Cigarette Smoke Condensate Extracts Induce IL-1-Beta Production from Rheumatoid Arthritis Patient-Derived Synoviocytes, but Not Osteoarthritis Patient-Derived Synoviocytes, Through Aryl Hydrocarbon Receptor-Dependent NF-Kappa-B Activation and Novel NF-Kappa-B Sites

Miki Adachi, Shosuke Okamoto, Satomi Chujyo et al. · Journal of Interferon & Cytokine Research · 2013 · 26 citations

Medicine, Immunology, Molecular Biology +13